Abeona Therapeutics Statistics
Total Valuation
ABEO has a market cap or net worth of $209.32 million. The enterprise value is $169.81 million.
| Market Cap | 209.32M |
| Enterprise Value | 169.81M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ABEO has 40.96 million shares outstanding. The number of shares has increased by 61.59% in one year.
| Shares Outstanding | 40.96M |
| Shares Change (YoY) | +61.59% |
| Shares Change (QoQ) | +27.76% |
| Owned by Insiders (%) | 3.24% |
| Owned by Institutions (%) | 61.28% |
| Float | 29.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 59.81 |
| Forward PS | 384.78 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 48.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.61
| Current Ratio | 5.61 |
| Quick Ratio | 5.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -59.41 |
Financial Efficiency
Return on equity (ROE) is -821.50% and return on invested capital (ROIC) is -334.70%.
| Return on Equity (ROE) | -821.50% |
| Return on Assets (ROA) | -118.60% |
| Return on Capital (ROIC) | -334.70% |
| Revenue Per Employee | $41,667 |
| Profits Per Employee | -$912,607 |
| Employee Count | 84 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.83% in the last 52 weeks. The beta is 1.58, so ABEO's price volatility has been higher than the market average.
| Beta (5Y) | 1.58 |
| 52-Week Price Change | +34.83% |
| 50-Day Moving Average | 4.52 |
| 200-Day Moving Average | 5.25 |
| Relative Strength Index (RSI) | 57.54 |
| Average Volume (20 Days) | 460,348 |
Short Selling Information
The latest short interest is 3.36 million, so 8.20% of the outstanding shares have been sold short.
| Short Interest | 3.36M |
| Short Previous Month | 2.65M |
| Short % of Shares Out | 8.20% |
| Short % of Float | 11.31% |
| Short Ratio (days to cover) | 7.05 |
Income Statement
In the last 12 months, ABEO had revenue of $3.50 million and -$76.66 million in losses. Loss per share was -$3.20.
| Revenue | 3.50M |
| Gross Profit | 3.50M |
| Operating Income | -47.82M |
| Pretax Income | -76.66M |
| Net Income | -76.66M |
| EBITDA | -72.36M |
| EBIT | -75.39M |
| Loss Per Share | -$3.20 |
Balance Sheet
The company has $62.68 million in cash and $23.17 million in debt, giving a net cash position of $39.51 million or $0.96 per share.
| Cash & Cash Equivalents | 62.68M |
| Total Debt | 23.17M |
| Net Cash | 39.51M |
| Net Cash Per Share | $0.96 |
| Equity (Book Value) | -8.88M |
| Book Value Per Share | -0.22 |
| Working Capital | 54.84M |
Cash Flow
In the last 12 months, operating cash flow was -$39.80 million and capital expenditures -$634,000, giving a free cash flow of -$40.44 million.
| Operating Cash Flow | -39.80M |
| Capital Expenditures | -634,000 |
| Free Cash Flow | -40.44M |
| FCF Per Share | -$1.48 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,366.34% and -2,190.26%.
| Gross Margin | 100.00% |
| Operating Margin | -1,366.34% |
| Pretax Margin | -2,190.26% |
| Profit Margin | -2,190.26% |
| EBITDA Margin | -2,067.31% |
| EBIT Margin | -2,154.00% |
| FCF Margin | -1,155.34% |
Dividends & Yields
ABEO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -61.59% |
| Shareholder Yield | -61.59% |
| Earnings Yield | -36.62% |
| FCF Yield | -19.32% |
Analyst Forecast
The average price target for ABEO is $19.00, which is 271.82% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.00 |
| Price Target Difference | 271.82% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 144.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 5, 2022. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jul 5, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ABEO has an Altman Z-Score of -15.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.51 |
| Piotroski F-Score | 2 |